A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP.

Journal title: Immunotherapy Advances

Journal publisher: Oxford University Press

Published year: 2021

Published pages: 2(1)

DOI identifier: 10.1093/immadv/ltab022

ISSN: 2732-4303